FDA official logo
GSRS logo
PFDA official logo

REMIMAZOLAM BESYLATE

  • UNII: 280XQ6482H
  • Formula: C21H19BrN4O2.C6H6O3S
  • Preferred Substance Name: REMIMAZOLAM BESYLATE
  • InChIKey: QMTKNJZIWGTNTE-LMOVPXPDSA-N

  • 1001415-66-2
  • 4H-IMIDAZO(1,2-A)(1,4)BENZODIAZEPINE-4-PROPANOIC ACID, 8-BROMO-1-METHYL-6-(2-PYRIDINYL)-, (4S)-, METHYL ESTER, BENZENESULFONATE (1:1)
  • BIPRAZINE PF
  • BYFAVO
  • CNS-7056 BESYLATE
  • CNS-7056B
  • GW502056X
  • GW-502056X
  • METHYL 3-((4S)-8-BROMO-1-METHYL-6-(PYRIDIN-2-YL)-4H-IMIDAZO(1,2-A)(1,4)BENZODIAZEPIN-4-YL)PROPANOATE, MONOBENZENESULFONATE
  • ONO-2745BS
  • ONO-IN-251
  • REMIMAZOLAM BESILATE
  • REMIMAZOLAM BESILATE [JAN]
  • REMIMAZOLAM BESYLATE [MI]
  • REMIMAZOLAM BESYLATE [ORANGE BOOK]
  • REMIMAZOLAM BESYLATE [USAN]
  • REMIMAZOLAM BESYLATE [WHO-DD]
  • RF10007
  • RF-10007
  • SP148.5

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.